{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T02:32:35Z","timestamp":1789698755829,"version":"4.0.1"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["#FRN94079"],"award-info":[{"award-number":["#FRN94079"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["#MOP119304"],"award-info":[{"award-number":["#MOP119304"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.expneurol.2017.12.002","type":"journal-article","created":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T19:11:31Z","timestamp":1512760291000},"page":"39-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"PA","title":["Impact of DHA intake in a mouse model of synucleinopathy"],"prefix":"10.1016","volume":"301","author":[{"given":"Katherine","family":"Coulombe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Kerdiles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyntia","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Emond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Lebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Boulianne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Plourde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Cicchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Calon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2017.12.002_bb0005","doi-asserted-by":"crossref","first-page":"10858","DOI":"10.1073\/pnas.0502903102","article-title":"Docosahexaenoic acid: a positive modulator of Akt signaling in neuronal survival","volume":"102","author":"Akbar","year":"2005","journal-title":"PNAS"},{"key":"10.1016\/j.expneurol.2017.12.002_bb0010","doi-asserted-by":"crossref","first-page":"e17397","DOI":"10.1371\/journal.pone.0017397","article-title":"DHA improves cognition and prevents dysfunction of entorhinal cortex neurons in 3xTg-AD mice","volume":"6","author":"Arsenault","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2017.12.002_bb0015","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.2353\/ajpath.2007.070373","article-title":"Polyunsaturated fatty acids induce alpha-synuclein-related pathogenic changes in neuronal cells","volume":"171","author":"Assayag","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0020","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.brainres.2015.06.002","article-title":"Post-translational modification of alpha-synuclein in Parkinson's disease","volume":"1628","author":"Barrett","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature10324","article-title":"\u03b1-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation","volume":"477","author":"Bartels","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2017.12.002_bb0030","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/mds.23696","article-title":"A tale on animal models of Parkinson's disease","volume":"26","author":"Bezard","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0035","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/mds.25108","article-title":"Animal models of Parkinson's disease: limits and relevance to neuroprotection studies","volume":"28","author":"Bezard","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0040","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1471-4159.1984.tb00906.x","article-title":"Alterations in the fatty acid composition of rat brain cells (neurons, astrocytes, and oligodendrocytes) and of subcellular fractions (myelin and synaptosomes) induced by a diet devoid of n-3 fatty acids","volume":"43","author":"Bourre","year":"1984","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0045","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1096\/fj.07-9677com","article-title":"Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease","volume":"22","author":"Bousquet","year":"2008","journal-title":"FASEB"},{"key":"10.1016\/j.expneurol.2017.12.002_bb0050","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.pnpbp.2009.07.018","article-title":"Modulation of brain-derived neurotrophic factor as a potential neuroprotective mechanism of action of omega-3 fatty acids in a parkinsonian animal model","volume":"33","author":"Bousquet","year":"2009","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2017.12.002_bb0055","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.arr.2011.03.001","article-title":"Impact of omega-3 fatty acids in Parkinson's disease","volume":"10","author":"Bousquet","year":"2011","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0060","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1194\/jlr.M011692","article-title":"Transgenic conversion of omega-6 into omega-3 fatty acids in a mouse model of Parkinson's disease","volume":"52","author":"Bousquet","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0065","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrn2652","article-title":"Tests to assess motor phenotype in mice: a user's guide","volume":"10","author":"Brooks","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0070","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1017\/S0029665113001031","article-title":"n-3 fatty acids, inflammation and immunity: new mechanisms to explain old actions","volume":"72","author":"Calder","year":"2013","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0075","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2217\/17460875.3.2.133","article-title":"Can we prevent Parkinson\u2019s disease with n-3 polyunsaturated fatty acids?","volume":"3","author":"Calon","year":"2008","journal-title":"Futur. Lipidol."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0080","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/syn.1045","article-title":"Effect of MPTP-induced denervation on basal ganglia GABAB receptors: correlation with dopamine concentrations and dopamine transporter","volume":"40","author":"Calon","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.expneurol.2017.12.002_bb0085","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.neuron.2004.08.013","article-title":"Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model","volume":"43","author":"Calon","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2017.12.002_bb0090","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.bbagen.2013.12.023","article-title":"Omega-3 deficiency and neurodegeneration in the substantia nigra: involvement of increased nitric oxide production and reduced BDNF expression","volume":"1840","author":"Cardoso","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2017.12.002_bb0095","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.plefa.2006.07.005","article-title":"Omega-3 fatty acids and monoamine neurotransmission","volume":"75","author":"Chalon","year":"2006","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.expneurol.2017.12.002_bb0100","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s13311-012-0104-2","article-title":"A progressive mouse model of Parkinson's disease: the Thy1-aSyn (\"line 61\") mice","volume":"9","author":"Chesselet","year":"2012","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.expneurol.2017.12.002_bb0105","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.nbd.2006.08.021","article-title":"Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: is this the target for Parkinson's disease?","volume":"25","author":"Chu","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0110","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jnutbio.2015.11.014","article-title":"Partial neurorescue effects of DHA following a 6-OHDA lesion of the mouse dopaminergic system","volume":"30","author":"Coulombe","year":"2016","journal-title":"J. Nutr. Biochem."},{"issue":"2\u20133","key":"10.1016\/j.expneurol.2017.12.002_bb0115","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jad.2008.03.008","article-title":"Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation","volume":"111","author":"da Silva","year":"2008","journal-title":"J. Affect. Disord."},{"issue":"1","key":"10.1016\/j.expneurol.2017.12.002_bb0120","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jmb.2009.09.008","article-title":"Molecular insights into the interaction between alpha-synuclein and docosahexaenoic acid","volume":"394","author":"De Franceschi","year":"2009","journal-title":"J. Mol. Biol."},{"issue":"17","key":"10.1016\/j.expneurol.2017.12.002_bb0125","doi-asserted-by":"crossref","first-page":"6927","DOI":"10.1074\/jbc.M116.765149","article-title":"Alpha-Synuclein structural features inhibit harmful polyunsaturated fatty acid oxidation, suggesting roles in neuroprotection","volume":"292","author":"De Franceschi","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0130","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1212\/01.WNL.0000166038.67153.9F","article-title":"Dietary fatty acids and the risk of Parkinson disease: the Rotterdam study","volume":"64","author":"de Lau","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2017.12.002_bb0135","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S1474-4422(15)00006-X","article-title":"Targeting \u03b1-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations","volume":"14","author":"Dehay","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0140","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.neures.2009.11.006","article-title":"Evaluation of chronic omega-3 fatty acids supplementation on behavioral and neurochemical alterations in 6-hydroxydopamine-lesion model of Parkinson' disease","volume":"66","author":"Delattre","year":"2010","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0145","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","article-title":"Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria","volume":"8","author":"Dickson","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0150","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.bbi.2012.02.007","article-title":"MyD88 deficiency results in both cognitive and motor impairments in mice","volume":"26","author":"Drouin-Ouellet","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0155","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0165-0270(91)90081-A","article-title":"A new motor test sensitive to aging and dopaminergic function","volume":"39","author":"Drucker-Col\u00edn","year":"1991","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.expneurol.2017.12.002_bb0160","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fnagi.2015.00052","article-title":"Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA","volume":"7","author":"Dyall","year":"2015","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0165","first-page":"865","article-title":"Mechanisms of alpha-synuclein action on neurotransmission: cell-autonomous and non-cell autonomous role","volume":"5","author":"Emanuele","year":"2015","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0170","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00008877-200609000-00004","article-title":"Behavioral phenotypes and pharmacology in genetic mouse models of Parkinsonism","volume":"17","author":"Fleming","year":"2006","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0175","doi-asserted-by":"crossref","first-page":"9434","DOI":"10.1523\/JNEUROSCI.3080-04.2004","article-title":"Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein","volume":"24","author":"Fleming","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0180","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/j.1471-4159.2009.06072.x","article-title":"Differences between subacute and chronic MPTP mice models: investigation of dopaminergic neuronal degeneration and alpha-synuclein inclusions","volume":"109","author":"Gibrat","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0185","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.bbr.2011.12.007","article-title":"Sensorimotor assessment of the unilateral 6-hydroxydopamine mouse model of Parkinson's disease","volume":"230","author":"Glajch","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0190","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1749-6632.2003.tb07475.x","article-title":"Transgenic models of \u03b1-synuclein pathology","volume":"991","author":"Hashimoto","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0195","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0304-3940(98)00599-0","article-title":"The native form of alpha-synuclein is not found in the cerebrospinal fluid of patients with Parkinson's disease or normal controls","volume":"253","author":"Jakowec","year":"1998","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.expneurol.2017.12.002_bb0200","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.parkreldis.2013.09.023","article-title":"Dietary fat intake, pesticide use, and Parkinson's disease","volume":"20","author":"Kamel","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0205","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1161\/STROKEAHA.111.620856","article-title":"Accumulation of dietary docosahexaenoic acid in the brain attenuates acute immune response and development of postischemic neuronal damage","volume":"42","author":"Lalancette-H\u00e9bert","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.expneurol.2017.12.002_bb0210","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/jnr.22611","article-title":"Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human \u03b1-synuclein","volume":"89","author":"Lam","year":"2011","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0215","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neuron.2006.09.026","article-title":"Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery","volume":"52","author":"Lee","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2017.12.002_bb0220","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.bbr.2011.09.033","article-title":"Ethyl-eicosapentaenoate (E-EPA) attenuates motor impairments and inflammation in the MPTP-probenecid mouse model of Parkinson's disease","volume":"226","author":"Luchtman","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0225","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3233\/JPD-140503","article-title":"Social cognition impairments in mice overexpressing alpha-synuclein under the Thy1 promoter, a model of pre-manifest Parkinson's disease","volume":"5","author":"Magen","year":"2015","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0230","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","article-title":"Dopaminergic loss and inclusion body formation in-synuclein mice: implications for neurodegenerative disorders","volume":"287","author":"Masliah","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2017.12.002_bb0235","first-page":"1","article-title":"Neuroprotective effect of omega-3 polyunsaturated fatty acids in the 6-OHDA model of Parkinson's disease is mediated by a reduction of inducible nitric oxide synthase","author":"Mori","year":"2017","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0240","series-title":"The Mouse Brain in Stereotaxic Coordinates","first-page":"242","author":"Paxinos","year":"2008"},{"key":"10.1016\/j.expneurol.2017.12.002_bb0245","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1017\/S000711450938215X","article-title":"Plasma n-3 fatty acid response to an n-3 fatty acid supplement is modulated by apoE epsilon4 but not by the common PPAR-alpha L162V polymorphism in men","volume":"102","author":"Plourde","year":"2009","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0250","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.nbd.2014.05.012","article-title":"Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons","volume":"69","author":"Richter","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0255","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S1474-4422(09)70293-5","article-title":"Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms","volume":"8","author":"Rodriguez-Oroz","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0260","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ana.21380","article-title":"Genomic investigation of alpha-synuclein multiplication and Parkinsonism","volume":"63","author":"Ross","year":"2008","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.expneurol.2017.12.002_bb0265","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.plipres.2010.05.004","article-title":"Alpha-synuclein, lipids and Parkinson's disease","volume":"49","author":"Ruiperez","year":"2010","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0270","series-title":"New Protective Roles for Selected Nutrients","first-page":"109","article-title":"Omega-3 fatty acids: molecular and biochemical aspects","author":"Salem","year":"1989"},{"issue":"1469\u20131480","key":"10.1016\/j.expneurol.2017.12.002_bb0275","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease","volume":"167","author":"Sampson","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2017.12.002_bb0280","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00401-010-0711-0","article-title":"The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia","volume":"120","author":"Schulz-Schaeffer","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0285","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fnagi.2014.00036","article-title":"The emerging role of nutrition in Parkinson's disease","volume":"6","author":"Seidl","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0290","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0896-6273(03)00024-2","article-title":"The formation of highly soluble oligomers of alpha-synulcein is regulated by fatty acids and enhanced in Parkinson's disease","volume":"37","author":"Sharon","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2017.12.002_bb0295","doi-asserted-by":"crossref","first-page":"49874","DOI":"10.1074\/jbc.M309127200","article-title":"Altered fatty acid composition of dopaminergic neurons expressing alpha-synuclein and human brains with alpha-synucleinopathies","volume":"278","author":"Sharon","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0300","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/brain\/awh081","article-title":"Association between cardiac denervation and Parkinsonism caused by alpha-synuclein gene triplication","volume":"127","author":"Singleton","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2017.12.002_bb0305","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/nan.12311","article-title":"Synucleinopathies: past, present and future","volume":"42","author":"Spillantini","year":"2016","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0310","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejphar.2015.05.045","article-title":"N-3 polyunsaturated fatty acids in animal models with neuroinflammation: an update","volume":"785","author":"Trepanier","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0315","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.nbd.2015.04.009","article-title":"Generation and characterization of novel conformation-specific monoclonal antibodies for alpha-synuclein pathology","volume":"79","author":"Vaikath","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0320","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","article-title":"Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death","volume":"72","author":"Volpicelli-Daley","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2017.12.002_bb0325","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.neuroscience.2009.01.021","article-title":"Alterations in corticostriatal synaptic plasticity in mice overexpressing human alpha-synuclein","volume":"159","author":"Watson","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2017.12.002_bb0330","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/jnr.22327","article-title":"Alpha-synuclein overexpression in mice alters synaptic communication in the corticostriatal pathway","volume":"88","author":"Wu","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2017.12.002_bb0335","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1750-3639.2011.00530.x","article-title":"Alpha-synuclein neuropathology is controlled by nuclear hormone receptors and enhanced by docosahexaenoic acid in a mouse model for Parkinson's disease","volume":"22","author":"Yakunin","year":"2012","journal-title":"Brain Pathol."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448861730331X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448861730331X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T15:16:17Z","timestamp":1719674177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448861730331X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":67,"alternative-id":["S001448861730331X"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2017.12.002","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of DHA intake in a mouse model of synucleinopathy","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2017.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}